Sullivan Lara
- SEC CIK
- 0001769457
No open-market purchases or sales filed in the past year.
Current role at each company
- PYXS Pyxis Oncology, Inc.President ,CEO & CMOas of Apr 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sullivan Lara as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2023 (view filing) | Sep 14-18 | 4 days | Sullivan LaraPresident and CEO | SSale | −8.64K | $2.10 | −$18.2K | −0.4%2.40M after | 2 lots |
| Sep 13, 2023 (view filing) | Sep 11-13 | 2 days | Sullivan LaraPresident and CEO | SSale | −27.9K | $2.27 | −$63.3K | −1.1%2.60M after | 3 lots |